“Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches” (2021) Biomolecules and Biomedicine, 21(3), pp. 270–283. doi:10.17305/bjbms.2020.5016.